Claim your 30% discount on Global Market Reports with code ONLINE30. Limited time only.

How Has The Panic Disorders Market Size Shifted, And What Is the Outlook Through 2034?

The market size for panic disorders has been experiencing a consistent upward trajectory in the past few years. It is projected to escalate from $10.73 billion in 2024 to $11.15 billion in 2025, marking a compound annual growth rate (CAGR) of 3.9%. This growth observed in the historical period can be credited to factors such as usage of antidepressant medications, heightened awareness of mental health, rising levels of stress, availability of mental health services, and improvements in diagnostic guidelines.

Anticipation is high for the expansion of the panic disorders market over the next several years. It is projected to reach a value of $13.97 billion by 2029, with a Compound Annual Growth Rate (CAGR) of 5.8%. Factors contributing to this expected growth during the forecast period include the advent of new pharmacological treatments, adoption of telepsychiatry services, emphasis on associated conditions, global efforts towards mental health, implementation of pharmacogenomics in treatment approaches and public enlightenment programs. Key trends forecasted for this period are digital interventions for mental health, telemedicine applications for the treatment of panic disorders, advancements in medication, research in the field of neurobiology, and the use of remote monitoring and wearable tech.

Download a free sample to assess the report’s scope and structure:

https://www.thebusinessresearchcompany.com/sample.aspx?id=13191&type=smp

Which Major Market Drivers Are Expected to Boost the Growth Potential of the Panic Disorders Market?

The surge in psychiatric patients is projected to stimulate the expansion of the panic disorder market in the future. People suffering from psychiatric disorders or mental illnesses often experience disruption in cognition, emotions, and social behavior, and this can lead to panic disorder or severe panic attacks. Various therapies, medications, and changes in lifestyle are usually adopted to treat these psychiatric patients and to alleviate panic attack symptoms, improving their overall life quality and providing them with efficient coping strategies. As an illustration, the State of Mental Health in America 2022 report, published by Mental Health America in October 2022, a non-profit organization in the US advocating for mental health, highlighted that the count of adults suffering from any mental difficulties escalated to 49,564,000, accounting for 19.86% of the total US population in 2022. This was a rise from 47,132,000, which composed 19.00% of the total US population in 2021. As a result of these increasing numbers of psychiatric patients, the panic disorder market is expected to grow.

Which Key Market Segments Comprise the Panic Disorders Market and Drive Its Revenue Growth?

The panic disordersmarket covered in this report is segmented –

1) By Type: Agoraphobia; Social Anxiety Disorder (SAD); Obsessive-Compulsive Disorder (OCD); Bipolar Disorder; Post-Traumatic Stress Disorder (PTSD); Major Depressive Disorder

2) By Treatment: Medication; Beta Blockers; Serotonin And Norepinephrine Reuptake Inhibitors (SNRIs); Benzodiazepines; Anti-Epilepsy; Other Treatments

3) By Route Of Administration: Oral; Parenteral; Other Routes Of Administrations

4) By End Use: Hospital Pharmacies; Retailer Pharmacies; Online Pharmacy Stores

Subsegments:

1) By Agoraphobia: Situational Agoraphobia; Non-Situational Agoraphobia

2) By Social Anxiety Disorder (SAD): Performance Anxiety; Generalized Social Anxiety

3) By Obsessive-Compulsive Disorder (OCD): Contamination OCD; Harm OCD; Checking OCD; Symmetry OCD

4) By Bipolar Disorder: Bipolar I Disorder; Bipolar II Disorder; Cyclothymic Disorder

5) By Post-Traumatic Stress Disorder (PTSD): Acute PTSD; Chronic PTSD; Complex PTSD

6) By Major Depressive Disorder: Recurrent Major Depressive Disorder; Single Episode Major Depressive Disorder

Request customized data on this market:

https://www.thebusinessresearchcompany.com/customise?id=13191&type=smp

Which Areas Are Leading Regions in the Panic Disorders Market Expansion Across the Globe?

North America was the largest region in the panic disorders market in 2024. Asia Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the panic disorders market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa

What Are the Key Market Trends in thePanic Disorders Market Over the Coming Years?

Leading organizations in the panic disorder sector are investing in the creation of more sophisticated treatments such as extended-release pills to retain a strong presence in the market. These types of drugs gradually dispense the active ingredient over a given period, typically 12 or 24 hours, providing a solution for conditions needing long-term medication. For example, in May 2023, Indian pharmaceutical firm Granules India Ltd. garnered Abbreviated New Drug Application (ANDA) approval from the US Food & Drug Administration (USFDA) for their creation of Venlafaxine hydrochloride extended-release capsules. These capsules display bioequivalence with the reference-listed drug product (RLD), Effexor XR Extended-Release Capsules, produced by Upjohn US 2 LLC. Venlafaxine HCl extended-release capsules are designed to manage a range of conditions such as generalized anxiety disorder (GAD), major depressive disorder (MDD), panic disorder (PD), and social anxiety disorder (SAD). The capsules function by elevating the levels of serotonin and norepinephrine in the brain, and the starting dosage is generally 75 mg per day, with adjustments made as deemed necessary by the doctor.

View the full report here:

https://www.thebusinessresearchcompany.com/report/panic-disorders-global-market-report

How Is the Panic Disorders Market Conceptually Defined?

Panic disorder is a specific type of anxiety illness characterized by unanticipated and recurrent attacks of high anxiety accompanied by physical symptoms such as shortness of breath, chest pain, heart palpitations, nausea, and abdominal discomfort. Panic disorder is generally treated with medication and psychotherapy.

Purchase the full report and get a swift delivery:

https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=13191

About The Business Research Company:

With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795

Europe +44 7882 955267

Asia & Others +44 7882 955267 & +91 8897263534

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model